Pangea Biomed
About
Pangea Biomed is redefining precision oncology by combining molecular biology with bioinformatics and machine learning. Their proprietary tumor intelligence platform, ENLIGHT, analyzes gene expression, epigenetics, and proteomics to uncover tumor vulnerabilities and predict patient response to therapy, going beyond genomic abnormalities. Pangea serves the oncology field by accelerating drug discovery, enabling personalized treatment nominations, and improving clinical efficiency.
Key facts
At-a-glance profile data
- Website
- pangeabiomed.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2019
- Employees
- 16
- Total funding
- $12M (Seed)
- Business model
- B2B, B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 15 Dec 2022 | Seed | $5M | NFX, Danny Tocatly |
| 7 Apr 2022 | Seed | $7M | NFX |
Tech stack
Detected on pangeabiomed.com, last scanned 22 Aug 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- SEO
- Rank Math
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Pangea Biomed raised?
Pangea Biomed has raised a total of $12M in funding. The most recent round on record is Seed.
How many employees does Pangea Biomed have?
Pangea Biomed has approximately 16 people on record.